This miRNA seems to be involved in the pathogenesis of diabetes and lipopolysaccharide injury [66, 67], but more intriguingly, its downregulation has been reported to be involved in the activation of NF-kB signalling and the PPARγ pathway [68, 69]. Here, NFKB1 is linked to diabetes mellitus.